Filing Details
- Accession Number:
- 0001179110-19-003120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 17:30:40
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 17:30:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695686 | J Joseph Manning | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2019-02-28 | 7,288 | $0.00 | 61,324 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2019-02-28 | 3,959 | $77.23 | 57,365 | No | 4 | F | Direct | |
Common Shares Without Par Value | Disposition | 2019-03-01 | 1,223 | $78.00 | 56,142 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.